WDFY3-AS2 has also been reported correlated with diverse of cancers such as ovarian cancer (Li et al., 2020b), glioma (Zheng et al., 2021b), and esophageal (Kong et al., 2021). This evidence concerns the gene WDFY3 and central nervous system cancer.